Aisling Capital Management LP Long-Term Concentrated

Location: New York, NY

CIK: 0001766721 · Show all filings

Period: Q4 2018 (Next →)

Filing Date: Feb 8, 2019

Total Value: $94.91M (100.0% shares, 0.0% debt)

Holdings (12)

— ObsEva SA (OBSV) 18.5%

Value $17.55M Shares 1,386,338 Est. Cost $12.66 Unrealized —

— Eidos Therapeutics, Inc. (EIDIX) 16.3%

Value $15.46M Shares 1,123,630 Est. Cost $13.76 Unrealized —

— AVROBIO, Inc. (AVRO) 12.9%

Value $12.27M Shares 736,998 Est. Cost $16.65 Unrealized —

— Marker Therapeutics, Inc. (MRKR) 11.7%

Value $11.1M Shares 2,000,000 Est. Cost $5.55 Unrealized —

— Biohaven Pharmaceutical Holding Company Ltd. (BHVN) 10.7%

Value $10.15M Shares 274,513 Est. Cost $36.98 Unrealized —

— Aeglea Biotherapeutics Inc (AGLE) 6.9%

Value $6.506M Shares 868,621 Est. Cost $7.49 Unrealized —

RCUS Arcus Biosciences, Inc. (RCUS) 6.1%

Value $5.778M Shares 536,513 Est. Cost $11.67 Unrealized 0.0%

ACRS Aclaris Theraputics Inc (ACRS) 4.9%

Value $4.689M Shares 634,455 Est. Cost $10.31 Unrealized 0.0%

— Verona Pharma plc (VRNA) 4.5%

Value $4.281M Shares 443,596 Est. Cost $9.65 Unrealized —

— Zosano Pharma Corporation (ZSAN) 3.6%

Value $3.392M Shares 1,600,000 Est. Cost $2.12 Unrealized —

— Nabriva Therapeutics plc (NBRV) 2.8%

Value $2.642M Shares 1,809,259 Est. Cost $1.46 Unrealized —

— Sunesis Pharmaceuticals, Inc. (SNSS) 1.2%

Value $1.092M Shares 2,600,000 Est. Cost $0.42 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	ObsEva SA (OBSV)	1,386,338	$17.55M	18.5%	$12.66	—	COM	H5861P103
—	Eidos Therapeutics, Inc. (EIDIX)	1,123,630	$15.46M	16.3%	$13.76	—	COM	28249H104
—	AVROBIO, Inc. (AVRO)	736,998	$12.27M	12.9%	$16.65	—	COM	05455M100
—	Marker Therapeutics, Inc. (MRKR)	2,000,000	$11.1M	11.7%	$5.55	—	COM	57055L107
—	Biohaven Pharmaceutical Holding Company Ltd. (BHVN)	274,513	$10.15M	10.7%	$36.98	—	COM	G11196105
—	Aeglea Biotherapeutics Inc (AGLE)	868,621	$6.506M	6.9%	$7.49	—	COM	00773J103
RCUS	Arcus Biosciences, Inc. (RCUS)	536,513	$5.778M	6.1%	$11.67	0.0%	COM	03969F109
ACRS	Aclaris Theraputics Inc (ACRS)	634,455	$4.689M	4.9%	$10.31	0.0%	COM	00461U105
—	Verona Pharma plc (VRNA)	443,596	$4.281M	4.5%	$9.65	—	COM	925050106
—	Zosano Pharma Corporation (ZSAN)	1,600,000	$3.392M	3.6%	$2.12	—	COM	98979H202
—	Nabriva Therapeutics plc (NBRV)	1,809,259	$2.642M	2.8%	$1.46	—	SHS	G63637105
—	Sunesis Pharmaceuticals, Inc. (SNSS)	2,600,000	$1.092M	1.2%	$0.42	—	COM	867328700